Pages that link to "Q5134875"
Jump to navigation
Jump to search
The following pages link to clofarabine (Q5134875):
Displaying 50 items.
- acute myeloid leukemia (Q264118) (← links)
- Ribonucleotide reductase regulatory subunit M2 (Q21108338) (← links)
- Ribonucleotide reductase catalytic subunit M1 (Q21121233) (← links)
- Evoltra (Q29005831) (← links)
- 6-(Het)aryl-7-deazapurine ribonucleosides as novel potent cytostatic agents (Q39772376) (← links)
- Clolar (Q47521379) (← links)
- TCR Alpha Beta T-cell and CD19 B-cell Depleted Peripheral Blood Stem Cell Transplantation Using the CliniMACS System for Patients With Non-Malignant Hematologic Disorders From Matched or Mismatched, Related or Unrelated Donors (Q61904950) (← links)
- Donor Stem Cell Transplantation Using α/β+ T-lymphocyte Depleted Grafts From HLA Mismatched Donors (Q61904952) (← links)
- Study of Clofarabine and Fludarabine Drug Exposure in Pediatric Bone Marrow Transplantation (HCT) (Q61906927) (← links)
- Oral Clofarabine for Relapsed/Refractory Non-Hodgkin Lymphoma (Q61914555) (← links)
- Clofarabine and High-Dose Melphalan Followed by Donor Stem Cell Transplant in Patients With Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Myelodysplastic Syndromes (Q61914864) (← links)
- Reduced Intensity AlloTransplant For Osteopetrosis (Q61915090) (← links)
- Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes (Q61920712) (← links)
- Clofarabine, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk and/or Advanced Hematologic Cancer or Other Disease (Q61921685) (← links)
- 2 Arm Study of Clofarabine IV in MDS Patients (Q61921814) (← links)
- Clofarabine in Treating Patients With T-Cell or Natural Killer-Cell Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous Treatment (Q61922403) (← links)
- A Study of Clofarabine for Older Patients With Newly Diagnosed Acute Myelogenous Leukemia (AML) (CLASSIC II) (Q61932758) (← links)
- Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia (Q61932947) (← links)
- Clofarabine, Cytarabine, and Filgrastim in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia, Advanced Myelodysplastic Syndrome, and/or Advanced Myeloproliferative Neoplasm (Q61935971) (← links)
- The Role of Maintenance Oral Clofarabine in Older Adults With Acute Myeloid Leukemia (Q61939360) (← links)
- Fludarabine-IV Busulfan ± Clofarabine and Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) (Q61955568) (← links)
- Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies (Q61955600) (← links)
- Clofarabine-cyclophosphamide as Salvage Therapy for Refractory and Relapsed Acute Lymphoblastic Leukemia (ALL) Adults (Q61957104) (← links)
- Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match (Q61957748) (← links)
- Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen (Q61965924) (← links)
- NHL16: Study For Newly Diagnosed Patients With Acute Lymphoblastic Lymphoma (Q61967240) (← links)
- Clofarabine, Cytarabine, and G-CSF in Treating Patients With Myelodysplastic Syndromes (Q61980128) (← links)
- Clofarabine and Cytarabine in Treating Patients With Acute Myeloid Leukemia With Minimal Residual Disease (Q61981243) (← links)
- Allogeneic Stem Cell Transplant With Clofarabine, Busulfan and Antithymocyte Globulin (ATG) for Adult Patients With High-risk Acute Myeloid Leukemia/Myelodysplastic Syndromes (AML/MDS) or Acute Lymphoblastic Leukemia (ALL) (Q61981266) (← links)
- Clofarabine vs Clofarabine in Plus With Low-Dose Ara-C in Previously Untreated Patients With Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndromes (MDS). (Q62110266) (← links)
- ClAraC or FLAMSA Followed by Stem Cell Transplantation to Treat High Risk AML or Advanced MDS (Q63321760) (← links)
- Clofarabine Plus Low-Dose Cytarabine for Patients With Higher-Risk Myelodysplastic Syndrome (MDS) (Q63321766) (← links)
- Clofarabine Pre-conditioning With Allogeneic Transplant for Acute Myeloid Leukaemia (AML) (Q63321859) (← links)
- Study of Clofarabine in Combination With Low Dose Cytarabine to Treat Myelodysplastic Syndromes (Q63337599) (← links)
- Clofarabine Salvage Therapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) (Q63339250) (← links)
- Trial of the Combination of Bortezomib and Clofarabine in Adults With Relapsed Solid Tumors (Q63590647) (← links)
- Clofarabine Followed By Lenalidomide for High-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia (Q63590987) (← links)
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations (Q63807824) (← links)
- Clofarabine, Idarubicin, and Cytarabine (CIA) Versus Fludarabine, Idarubicin, and Cytarabine (FLAI) in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (Q63814249) (← links)
- Clofarabine or High-Dose Cytarabine and Pegaspargase in Children With ALL (Q63816596) (← links)
- Clofarabine and Low-Dose Total-Body Irradiation in Treating Patients With Acute Myeloid Leukemia Undergoing Donor Peripheral Blood Stem Cell Transplant (Q63818689) (← links)
- HLA-Compatible Related or Unrelated Donors With CD34+ Enriched, T-cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System in the Treatment of Patients With Hematologic Malignancies (Q63830715) (← links)
- PK Study of Oral and IV Clofarabine in High Risk Myelodysplasia+Acute Leukemias (Q63832170) (← links)
- Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia (Q63834767) (← links)
- Entinostat and Clofarabine in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Poor-Risk Acute Lymphoblastic Leukemia or Bilineage/Biphenotypic Leukemia (Q63835060) (← links)
- A Study of Clofarabine in Japanese Patients With Acute Myeloid Leukemia (AML) (Q63835509) (← links)
- Clofarabine, Cytarabine, and Filgrastim Followed by Infusion of Non-HLA Matched Ex Vivo Expanded Cord Blood Progenitors in Treating Patients With Acute Myeloid Leukemia (Q63837112) (← links)
- Reduced-Intensity Hematopoietic Stem Cell Transplant for High Risk Lysosomal and Peroxisomal Disorders (Q63838865) (← links)
- A Phase II Open-Label Study of High-Dose Cytarabine and Clofarabine in Adult Patients With Refractory or Relapsed Acute Myelogenous Leukemia or Refractory or Relapsed Acute Lymphoblastic Leukemia (Q64029833) (← links)
- Busulfan/Clofarabine + Allogeneic Stem Cell Transplantation (Q64030379) (← links)